Skip to Content

Watson 370 10 mg (Loxapine 10 mg)

Pill with imprint Watson 370 10 mg is White & Yellow, Capsule-shape and has been identified as Loxapine succinate 10 mg. It is supplied by Watson Laboratories, Inc..

Loxapine is used in the treatment of schizophrenia; agitated state; agitation and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 370 10 mg

Loxapine succinate 10 mg Watson 370 10 mg
Loxapine succinate 10 mg Watson 370 10 mg
Loxapine succinate 10 mg Watson 370 10 mg

Loxapine succinate

Watson 370 10 mg
10 mg
White & Yellow
18.00 mm
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
lactose anhydrous
benzyl alcohol
edetate calcium disodium
magnesium stearate
polacrilin potassium
sodium lauryl sulfate
sodium propionate
magnesium silicate
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0901 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.